Search Results - "Naphak Modhiran"

Author Correction: A single residue in the yellow fever virus envelope protein modulates virion architecture and antigenicity

Authors: Summa Bibby James Jung Yu Shang Low et al.

Source: Nature Communications, Vol 16, Iss 1, Pp 1-1 (2025)

Subject Terms: Science

File Description: electronic resource

Relation: https://doaj.org/toc/2041-1723

Access URL: https://doaj.org/article/d58f8c060b184380b25dcfec3b3ee109

Author Correction: Development of molecular clamp stabilized hemagglutinin vaccines for Influenza A viruses

Authors: Christopher L. D. McMillan Stacey T. M. Cheung Naphak Modhiran et al.

Source: NPJ Vaccines
npj Vaccines, Vol 7, Iss 1, Pp 1-1 (2022)

Subject Terms: 0301 basic medicine, 03 medical and health sciences, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Immunologic diseases. Allergy, RC581-607, Author Correction, RC254-282, 3. Good health

Access URL: https://www.nature.com/articles/s41541-021-00428-y.pdf
https://doaj.org/article/151199cb919648ddb1dacc00019af7b5

Author Reply to Peer Reviews of Multiple animal viruses, including SARS-CoV-2 and its variants, can use alternative cell entry mechanisms for infection

Authors: Ravi Ojha Anmin Jiang Elina Mäntylä et al.

Author Correction: A single residue in the yellow fever virus envelope protein modulates virion architecture and antigenicity.

Authors: Bibby, Summa Jung, James Low, Yu Shang et al.

Source: Nature Communications; 11/5/2025, Vol. 16 Issue 1, p1-1, 1p

A second-generation molecular clamp stabilised bivalent candidate vaccine for protection against diseases caused by respiratory syncytial virus and human metapneumovirus.

Authors: Young, Andrew Kolekar, Sharada Mendoza, Carlos Alvarez et al.

Source: PLoS Pathogens; 7/17/2025, Vol. 21 Issue 7, p1-20, 20p

Subject Terms: RESPIRATORY syncytial virus infections, VACCINE trials, RESPIRATORY infections, RESPIRATORY syncytial virus infection vaccines, RESPIRATORY diseases

Author Correction: Development of molecular clamp stabilized hemagglutinin vaccines for Influenza A viruses.

Authors: McMillan, Christopher L. D. Cheung, Stacey T. M. Modhiran, Naphak et al.

Source: NPJ Vaccines; 1/5/2022, Vol. 7 Issue 1, p1-1, 1p

Subject Terms: INFLUENZA vaccines, INFLUENZA, HEMAGGLUTININ

Intranasal delivery of engineered anti-SARS-CoV-2 extracellular vesicles therapeutically represses lung infection and inflammation.

Authors: Idris, Adi Shrivastava, Surya Gao, Wenqing et al.

Source: Drug Delivery & Translational Research; Nov2025, Vol. 15 Issue 11, p4115-4125, 11p

A unified route for flavivirus structures uncovers essential pocket factors conserved across pathogenic viruses

Authors: Joshua M. Hardy Natalee D. Newton Naphak Modhiran et al.

Source: Nature Communications, Vol 12, Iss 1, Pp 1-13 (2021)

Subject Terms: Science

File Description: electronic resource

Relation: https://doaj.org/toc/2041-1723

Access URL: https://doaj.org/article/e01baa3c70744276b2e3dffa7df9e256

A versatile reverse genetics platform for SARS-CoV-2 and other positive-strand RNA viruses

Authors: Alberto A. Amarilla Julian D. J. Sng Rhys Parry et al.

Source: Nature Communications, Vol 12, Iss 1, Pp 1-15 (2021)

Subject Terms: Science

File Description: electronic resource

Relation: https://doaj.org/toc/2041-1723

Access URL: https://doaj.org/article/2d42390e6b6242feac70593cf3d675b1

Systems serology detects functionally distinct coronavirus antibody features in children and elderly

Authors: Kevin J. Selva Carolien E. van de Sandt Melissa M. Lemke et al.

Source: Nature Communications, Vol 12, Iss 1, Pp 1-14 (2021)

Subject Terms: Science

File Description: electronic resource

Relation: https://doaj.org/toc/2041-1723

Access URL: https://doaj.org/article/b3735969bc2442d3bede1a835ba02866

A single residue in the yellow fever virus envelope protein modulates virion architecture and antigenicity.

Authors: Bibby, Summa Jung, James Low, Yu Shang et al.

Source: Nature Communications; 9/26/2025, Vol. 16 Issue 1, p1-15, 15p

Subject Terms: YELLOW fever, VIRAL envelope proteins, CRYOMICROSCOPY, IMMUNE recognition, PATHOGENIC microorganisms, ANTIGENS, VIROLOGY, VACCINES

Equal Maintenance of Anti-SARS-CoV-2 Antibody Levels Induced by Heterologous and Homologous Regimens of the BNT162b2, ChAdOx1, CoronaVac and Ad26.COV2.S Vaccines: A Longitudinal Study Up to the 4th Dose of Booster.

Authors: do Nascimento, Tatiana A. Nogami, Patricia Y. de Oliveira, Camille F. et al.

Source: Vaccines; Jul2024, Vol. 12 Issue 7, p792, 14p

Subject Terms: BOOSTER vaccines, SARS-CoV-2 Delta variant, SARS-CoV-2, GENETIC vectors, VACCINE effectiveness

Cryo-EM structure of severe fever with thrombocytopenia syndrome virus.

Authors: Du, Shouwen Peng, Ruchao Xu, Wang et al.

Source: Nature Communications; 10/10/2023, Vol. 14 Issue 1, p1-14, 14p

Subject Terms: FEVER, THROMBOCYTOPENIA, MEMBRANE fusion, SYNDROMES, MEMBRANE glycoproteins, VACCINE development, MAGNETIC particle imaging

Structure and antigenicity of divergent Henipavirus fusion glycoproteins.

Authors: Isaacs, Ariel Low, Yu Shang Macauslane, Kyle L. et al.

Source: Nature Communications; 6/16/2023, Vol. 14 Issue 1, p1-10, 10p

Subject Terms: HENIPAVIRUSES, GLYCOPROTEINS, ZOONOSES, ELECTRON microscopy, NONINVASIVE ventilation, GLYCANS

Geographic Terms: CHINA

Human Infection with Avian Influenza A(H9N2) Virus, Vietnam, April 2024.

Authors: Minh Hang Duong Thi Ngoc Uyen Phan Trung Hieu Nguyen et al.

Source: Emerging Infectious Diseases; Feb2025, Vol. 31 Issue 2, p388-392, 5p

Subject Terms: COMMUNICABLE diseases, INFECTION, INFLUENZA, HUMAN beings

Geographic Terms: VIETNAM

Serum-Free Suspension Culture of the Aedes albopictus C6/36 Cell Line for Chimeric Orthoflavivirus Vaccine Production.

Authors: Dawurung, Joshua S. Harrison, Jessica J. Modhiran, Naphak et al.

Source: Viruses (1999-4915); Feb2025, Vol. 17 Issue 2, p250, 16p

Subject Terms: JAPANESE encephalitis viruses, AEDES albopictus, CELL aggregation, VIRAL vaccines, CELL suspensions, WEST Nile virus, DENGUE viruses

Systems serology detects functionally distinct coronavirus antibody features in children and elderly.

Authors: Selva, Kevin J. van de Sandt, Carolien E. Lemke, Melissa M. et al.

Source: Nature Communications; 4/1/2021, Vol. 12 Issue 1, p1-14, 14p

Subject Terms: COVID-19, CORONAVIRUSES, SEROLOGY, SARS-CoV-2, PANDEMICS, COVID-19 vaccines

Inactivation of SARS‐CoV‐2 infectivity in platelet concentrates or plasma following treatment with ultraviolet C light or with methylene blue combined with visible light.

Authors: Hobson‐Peters, Jody Amarilla, Alberto A. Rustanti, Lina et al.

Source: Transfusion; Feb2023, Vol. 63 Issue 2, p288-293, 6p

Subject Terms: SARS-CoV-2, METHYLENE blue, VISIBLE spectra, BLUE light

Absence of Anti-RBD Antibodies in SARS-CoV-2 Infected or Naive Individuals Prior to Vaccination with CoronaVac Leads to Short Protection of Only Four Months Duration.

Authors: Oliveira, Camille F. de Neto, Walter F. F. Silva, Carla P. da et al.

Source: Vaccines; May2022, Vol. 10 Issue 5, p690-690, 13p

Subject Terms: COVID-19 vaccines, BOOSTER vaccines, VACCINATION, SARS-CoV-2, SARS-CoV-2 Omicron variant

Geographic Terms: BRAZIL

ACE2-Decorated Virus-Like Particles Effectively Block SARS-CoV-2 Infection.

Authors: Bayraktar, Canan Kayabolen, Alisan Odabas, Arda et al.

Source: International Journal of Nanomedicine; Jul2024, Vol. 19, p6931-6943, 13p